Article Details

Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q2 2022 Results - Seeking Alpha

Retrieved on: 2022-08-07 01:04:36

Tags for this article:

Click the tags to see associated articles and topics

Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q2 2022 Results - Seeking Alpha. View article details on hiswai:

Excerpt

Eiger BioPharmaceuticals, Inc. (NASDAQ:NASDAQ:EIGR) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Sarah ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up